West Pharmaceutical Sets 2024 EPS Guidance at $7.50-$7.75

WST reported a robust fourth-quarter with net sales of $732.0 million, marking a 3.3% increase.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.